NOVEMBER 2023LIFE SCIENCES REVIEW5CXO INSIGHTSCXO INSIGHTSTechnological advancements for industrial revolution 4.0Alessandro Gazzotti, Operations Director, Bormioli Pharma243D bioprinting: Accelerating Drug DiscoveryItedale Namro Redwan, Chief Scientific Officer, Director of Bioink and Tissue Engineering R&D,CELLINK20The value of new antibiotics in the fight against AMRPiero Rijli, Corporate Director, Regulatory Activities and Market Access, MENARINI Group22The Revolutionary Power of Cell and Gene TherapiesStefano Baila, Managing Director Biologics, Eurofins1826Discovering the Medicines of the FutureAraz Raoof, Senior Vice President Global Drug Discovery & External Innovation, Ferring Pharmaceuticals28Risk-based Approach in Vendor Assessment for Clinical Trials (CT) ServicesInguna Adovica, Head of Clinical Research Quality Division, &Vadims sis, Head of Medicine and Clinical Research Department, JSC OlainfarmFEATURED COMPANYMDRC16Jozef Kovac,Owner of MDRCTOP 10SERVICES PROVIDERS IN EUROPE 2023Life ScienceRegulatory
< Page 4 | Page 6 >